Targeting Hope Gala

OHSU offers select multimedia assets for use by news outlets. (Commercial use is prohibited without prior written consent.)

When using these materials, please:

  • Credit photos and video with “OHSU/Photographer name.” Photographer name, caption and usage restrictions are embedded in the image metadata.  Do not alter the content/nature of the photo. Color correction and cropping are allowed.

  • Audio and video clips should be credited to OHSU.

For more information, please contact OHSU Strategic Communications at news@ohsu.edu or 503-494-8231.

VIDEO DOWNLOAD: Katy Knudson, patient story
VIDEO DOWNLOAD: Katy Knudson, patient story

Katie Knudson, 18, was one of the first children to be treated with Gleevec for chronic myeloid leukemia.

VIDEO DOWNLOAD: Phil Knight announces $1 billion cancer challenge
VIDEO DOWNLOAD: Phil Knight announces $1 billion cancer challenge

Nike Co-founder Phil Knight announces the $1 billion challenge to end cancer as we know it at the Targeting Hope gala benefiting the OHSU Knight Cancer Institute in September 2013.

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. From left: Stephen S. Pawlowski, OHSU Foundation Board of Trustees member and Intel senior fellow and Data Center Group chief technology officer, speaks with Oregon Governor John Kitzhaber and First Lady Cylvia Hayes at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. OHSU President Joe Robertson Jr., M.D., M.B.A., (left) speaks with then Oregon Governor John Kitzhaber at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. A festive crowd of about 400 supporters celebrates at the Targeting Hope gala, benefiting the OHSU Knight Cancer Institute, in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. Katie Knudson, 18, was one of the first children to be treated with Gleevec for chronic myeloid leukemia. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. A crowd of about 400 people watch as OHSU President Joe Robertson Jr., M.D., M.B.A., speaks at the Targeting Hope gala benefiting the OHSU Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. OHSU President Joe Robertson Jr., M.D., M.B.A., speaks at the 2013 Targeting Hope gala in Portland after Nike Co-founder Phil Knight announces his $1 billion cancer challenge. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. Nike Co-founder Phil Knight talks with Tim Boyle, president and chief executive officer of Columbia Sportswear, at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. From left: Tim Boyle, president and chief executive officer of Columbia Sportswear; Nike Co-founder Phil Knight; Wieden+Kennedy Co-founder Dan Wieden; and Brian Druker, M.D., director of the Knight Cancer Institute, pose for a photo at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. From left: Tim Boyle, president and chief executive officer of Columbia Sportswear; Nike Co-founder Phil Knight; Wieden+Kennedy Co-founder Dan Wieden; and Brian Druker, M.D., director of the Knight Cancer Institute, speak at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. From left: Tim Boyle, president and chief executive officer of Columbia Sportswear; Nike Co-founder Phil Knight; Wieden+Kennedy Co-founder Dan Wieden; and Brian Druker, M.D., director of the Knight Cancer Institute, at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. Brian Druker, M.D., director of the Knight Cancer Institute, and his wife, Alex, pose for a photo at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope gala for the Knight Cancer Institute in September 2013. Katie Knudson (second from left) and her family celebrate with Brian Druker, M.D., right, after Phil Knight announces his $1 billion cancer challenge at the Targeting Hope gala in September 2013. At age 6, Knudson was one of the first children to receive Gleevec, the targeted cancer therapy that was developed by Dr. Druker. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. Nike Co-founder Phil Knight announces the $1 billion challenge to end cancer as we know it at the Targeting Hope gala benefiting the OHSU Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. From left: Longtime friends Ken O’Neil (left) and Nike Co-founder Phil Knight (center) share a laugh with Michael Doherty, Nike’s Creative Director of Global Brand Presentations, at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. From left: Nike Co-founder Phil Knight; former Louisiana-Pacific Chief Executive Officer Harry Merlo; and Flo Newton, president of Global Aviation, speak at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. From left: Wim Wiewel, Portland State University president; Edward J. Ray, Oregon State University president; and Joe Robertson Jr., M.D., M.B.A., OHSU president, attend the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)

Targeting Hope Gala
Targeting Hope Gala

Targeting Hope Event. Brian Druker, M.D., (center) shares a moment with Nike Co-founder Phil Knight and his wife, Penny, at the Targeting Hope gala for the Knight Cancer Institute in September 2013. (OHSU)